Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time

BACKGROUND: Microvascular obstruction affects one-half of patients with ST-segment elevation myocardial infarction and confers an adverse prognosis. OBJECTIVES: This study aimed to determine whether the efficacy and safety of a therapeutic strategy involving low-dose intracoronary alteplase infused...

Descripción completa

Detalles Bibliográficos
Autores principales: McCartney, Peter J., Maznyczka, Annette M., Eteiba, Hany, McEntegart, Margaret, Oldroyd, Keith G., Greenwood, John P., Maredia, Neil, Schmitt, Matthias, McCann, Gerry P., Fairbairn, Timothy, McAlindon, Elisa, Tait, Campbell, Welsh, Paul, Sattar, Naveed, Orchard, Vanessa, Corcoran, David, Ford, Thomas J., Radjenovic, Aleksandra, Ford, Ian, McConnachie, Alex, Berry, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Biomedical 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109518/
https://www.ncbi.nlm.nih.gov/pubmed/32216909
http://dx.doi.org/10.1016/j.jacc.2020.01.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109518/
https://www.ncbi.nlm.nih.gov/pubmed/32216909
http://dx.doi.org/10.1016/j.jacc.2020.01.041

Ejemplares similares